SEC Form 4 · accession 0001479791-17-000003
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Dec 20, 2017
Accepted (ET)
Dec 22, 2017 · 2:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common stock | Dec 20, 2017 | S | 10,000 | $0.172 | D | 26,193,122 | D |
Table II — derivative securities
No Table II lines on this filing.